(Total Views: 86)
Posted On: 01/02/2024 1:15:50 PM
Post# of 107057
$BMY News Article - European Medicines Agency Validates Bristol Myers Squibb's Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive Solid Tumors https://marketwirenews.com/news-releases/euro...47892.html
(0)
(0)
My Twitter: WhyteStocks
